Abstract
Acute myeloid leukemia (AML) is the most common type of acute leukemia in adults. AML is a heterogeneous malignancy characterized by distinct genetic and epigenetic abnormalities. Recent genome-wide DNA methylation studies have highlighted an important role of dysregulated methylation signature in AML from biological and clinical standpoint. In this review, we will outline the recent advances in the methylome study of AML and overview the impacts of DNA methylation on AML diagnosis, treatment, and prognosis.
Author supplied keywords
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Cite
CITATION STYLE
Li, Y., Xu, Q., Lv, N., Wang, L., Zhao, H., Wang, X., … Yu, L. (2017, February 2). Clinical implications of genome-wide DNA methylation studies in acute myeloid leukemia. Journal of Hematology and Oncology. BioMed Central Ltd. https://doi.org/10.1186/s13045-017-0409-z
Readers over time
Readers' Seniority
Readers' Discipline
